The Peter Attia Drive cover image

#148 - Richard Miller, M.D., Ph.D.: The gold standard for testing longevity drugs: the Interventions Testing Program

The Peter Attia Drive

00:00

Exploring Diabetes Drugs and Longevity

This chapter investigates the diabetes medication acarbose and its effects on glucose absorption, exploring its potential role in mimicking caloric restriction and implications for longevity research. The speakers also discuss canagliflozin and delve into the complexities of testing compounds like SGLT2 inhibitors in mice, highlighting challenges in evaluating weight changes and gastrointestinal distress. Additionally, the chapter critiques the commercialization of resveratrol as an anti-aging supplement, presenting scientifically-backed skepticism regarding its efficacy and the ongoing debates within longevity research.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app